The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study
NCT ID: NCT06471166
Last Updated: 2024-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2024-07-10
2025-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Expectant Management of Ectopic Pregnancy
NCT04975984
The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy
NCT02714998
Different Treatment Options for Tubal Ectopic Pregnancy:- A Systmatic Review
NCT04951011
Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy
NCT06426979
The Selection of Pregnancy for Patients After Tubal Ectopic Pregnancy Treatment
NCT05498558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conservative management
Amh hormone
Ovarian reserve
Medical treatment
Amh hormone
Ovarian reserve
Surgical treatment (Open or laparoscopic salpingectomy)
Amh hormone
Ovarian reserve
Surgical treatment after failed medical treatment (Open or laparoscopic salpingectomy)
Amh hormone
Ovarian reserve
Conservative surgical treatment (salpingotomy, salpingostomy, tubal milking)
Amh hormone
Ovarian reserve
Conservative surgical treatment after failed medical treatment
Amh hormone
Ovarian reserve
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amh hormone
Ovarian reserve
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Included patients must have capacity to provide informed consent. Given the potential emergent nature of presentation, women will not be recruited if fully informed consent could be compromised due to a highly distressed emotional state or significant hemorrhage necessitating the need for urgent surgery
Exclusion Criteria
2. If other surgery was conducted at the time of salpingectomy.
3. If a woman was pregnant at follow up visit for AMH measurement
4. History of previous surgeries of fallopian tubes and/or ovaries
18 Years
44 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andro Bahgat Heshmat
Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Andro Bahgat, Md
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ectopic pregnancy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.